Breaking News Instant updates and real-time market news.

SHPG

Shire

$178.95

2.67 (1.51%)

, TKPYY

Takeda Pharmaceutical

$0.00

(0.00%)

09:39
11/06/18
11/06
09:39
11/06/18
09:39

Shire price target lowered to $190 from $205 at SunTrust

SunTrust analyst John Boris lowered his price target on Shire (SHPG) to $190 to reflect the impact of the USD appreciation against GBP while also lowering his FY18 EPS view to $15.11 from $15.18. The analyst notes that the investment focus for Shire falls on the November 20th vote by E.U. regulators on its merger with Takeda (TKPYY), adding that the company is on track to secure that approval and for shareholders to vote on the deal in January of next year.

SHPG

Shire

$178.95

2.67 (1.51%)

TKPYY

Takeda Pharmaceutical

$0.00

(0.00%)

  • 21

    Dec

SHPG Shire
$178.95

2.67 (1.51%)

09/07/18
BREN
09/07/18
DOWNGRADE
BREN
Hold
Shire downgraded to Hold from Buy at Berenberg
Berenberg analyst Klara Fernandes downgraded Shire (SHPG) to Hold saying the current valuation offers limited potential upside ahead of the pending takeover by Takeda Pharmaceutical (TKPYY).
09/04/18
09/04/18
DOWNGRADE

Market Perform
Shire downgraded to Market Perform as spread narrows at Bernstein
As previously reported, Bernstein analyst Aaron Gal downgraded Shire (SHPG) to Market Perform from Outperform. The analyst notes that he current controversy on Shire is the risk/reward into the closing of the Takeda (TKPYY) acquisition, and over the past few weeks deal spread narrowed, and the fundamentals have gotten a bit tougher in ADHD, HAE and Hemophilia.
09/04/18
BERN
09/04/18
DOWNGRADE
BERN
Market Perform
Shire downgraded to Market Perform from Outperform at Bernstein
05/09/18
LEER
05/09/18
NO CHANGE
LEER
Takeda/Shire transaction shows path for consolidation, says Leerink
Leerink analyst Geoffrey Porges notes that Takeda (TKPYY) confirmed its intention and agreement to purchase Shire (SHPG) for $62B in cash and stock. For the broader biopharma industry, the analyst believes Takeda's ability to lever up to an estimated 5.4x net debt/EBITDA suggests that investors are underestimating the ability of large cap biopharma companies to pursue large transactions. Nearly all of the large cap biopharma companies face looming growth issues or suffer under revenue-concentration risk discounts that could be mitigated by large-scale acquisitions, he contends. Porges believes that if Takeda can execute the Shire acquisition while checking the boxes of investor demands of a net positive ROIC, instant EPS accretion, maintaining an investment grade credit rating, and massive synergy savings, then others in the biopharma industry with stronger balance sheets and larger valuations can contemplate transactions that are substantially larger even than Shire.
TKPYY Takeda Pharmaceutical
$0.00

(0.00%)

04/25/18
RHCO
04/25/18
NO CHANGE
Target $205
RHCO
Buy
Shire price target raised to $205 from $190 at SunTrust
SunTrust analyst John Boris raised his price target on Shire (SHPG) to $205 and kept his Buy rating after an updated merger proposal from Takeda (TKPYY), which has until May 8th to make the final offer. Boris believes the combined stock-and-cash offer of $205 is high enough for Shire shareholders to accept the terms, and other bidders could potentially emerge based on its positive catalysts such as Neuroscience strategic review and LANA August PDUFA.

TODAY'S FREE FLY STORIES

DAL

Delta Air Lines

$55.88

-0.21 (-0.37%)

06:25
11/19/18
11/19
06:25
11/19/18
06:25
Initiation
Delta Air Lines initiated  »

Delta Air Lines initiated…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

ALK

Alaska Air

$67.68

0.29 (0.43%)

06:23
11/19/18
11/19
06:23
11/19/18
06:23
Initiation
Alaska Air initiated  »

Alaska Air initiated with…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 27

    Nov

GE

General Electric

$8.04

-0.135 (-1.65%)

, SIEGY

Siemens

$0.00

(0.00%)

06:21
11/19/18
11/19
06:21
11/19/18
06:21
Periodicals
GE chases power sales in Iraq as report highlights corruption concerns, WSJ says »

General Electric (GE) has…

GE

General Electric

$8.04

-0.135 (-1.65%)

SIEGY

Siemens

$0.00

(0.00%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

GPX

GP Strategies

$14.14

-0.03 (-0.21%)

06:20
11/19/18
11/19
06:20
11/19/18
06:20
Hot Stocks
GP Strategies awarded multi-year contract extension from banking organization »

GP Strategies announced…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

SCHW

Charles Schwab

$46.97

-0.35 (-0.74%)

, AMTD

TD Ameritrade

$52.32

-0.28 (-0.53%)

06:20
11/19/18
11/19
06:20
11/19/18
06:20
Downgrade
Charles Schwab, TD Ameritrade rating change  »

Charles Schwab downgraded…

SCHW

Charles Schwab

$46.97

-0.35 (-0.74%)

AMTD

TD Ameritrade

$52.32

-0.28 (-0.53%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

GHG

GreenTree Hospitality

$12.53

0.01 (0.08%)

06:18
11/19/18
11/19
06:18
11/19/18
06:18
Earnings
Breaking Earnings news story on GreenTree Hospitality »

GreenTree Hospitality…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 19

    Nov

AMTD

TD Ameritrade

$52.32

-0.28 (-0.53%)

06:17
11/19/18
11/19
06:17
11/19/18
06:17
Upgrade
TD Ameritrade rating change  »

TD Ameritrade upgraded to…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

GHG

GreenTree Hospitality

$12.53

0.01 (0.08%)

06:16
11/19/18
11/19
06:16
11/19/18
06:16
Earnings
GreenTree Hospitality reports Q3 core EPS 18c , two estimates 19c »

Reports Q3 revenue…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 19

    Nov

CTSH

Cognizant

$70.10

1.63 (2.38%)

06:15
11/19/18
11/19
06:15
11/19/18
06:15
Recommendations
Cognizant analyst commentary  »

Confidence in Cognizant…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 26

    Nov

  • 02

    Dec

  • 04

    Dec

06:15
11/19/18
11/19
06:15
11/19/18
06:15
General news
Risk aversion picks up on reports that Renault-Nissan Ghosn has been arrested. »

Risk aversion picks up on…

YETI

Yeti

$16.99

0.1 (0.59%)

06:13
11/19/18
11/19
06:13
11/19/18
06:13
Initiation
Yeti initiated  »

Yeti initiated with an…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 29

    Nov

TSLA

Tesla

$354.46

6.09 (1.75%)

06:12
11/19/18
11/19
06:12
11/19/18
06:12
Conference/Events
Tesla management to meet with RBC Capital »

Group luncheon with…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 19

    Nov

  • 19

    Nov

  • 27

    Nov

  • 13

    Dec

HP

Helmerich & Payne

$62.59

2.54 (4.23%)

06:12
11/19/18
11/19
06:12
11/19/18
06:12
Upgrade
Helmerich & Payne rating change  »

Helmerich & Payne…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

WTI

W&T Offshore

$6.13

0.02 (0.33%)

06:11
11/19/18
11/19
06:11
11/19/18
06:11
Conference/Events
W&T Offshore management to meet with Seaport Global »

Meetings to be held in…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 19

    Nov

  • 20

    Nov

EV

Eaton Vance

$42.62

-0.435 (-1.01%)

06:11
11/19/18
11/19
06:11
11/19/18
06:11
Downgrade
Eaton Vance rating change  »

Eaton Vance downgraded to…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

TPR

Tapestry

$40.63

-0.36 (-0.88%)

06:10
11/19/18
11/19
06:10
11/19/18
06:10
Conference/Events
Tapestry management to meet with MKM Partners »

Meeting to be held in New…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 19

    Nov

TPR

Tapestry

$40.63

-0.36 (-0.88%)

06:10
11/19/18
11/19
06:10
11/19/18
06:10
Conference/Events
Tapestry management to meet with MKM Partners »

Meeting to be held in New…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 19

    Nov

USB

U.S. Bancorp

$54.93

0.26 (0.48%)

06:10
11/19/18
11/19
06:10
11/19/18
06:10
Recommendations
U.S. Bancorp analyst commentary  »

U.S. Bancorp positioned…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

TELL

Tellurian

$8.03

0.11 (1.39%)

06:10
11/19/18
11/19
06:10
11/19/18
06:10
Conference/Events
Tellurian management to meet with Seaport Global »

Meeting to be held in…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 19

    Nov

CRM

Salesforce

$132.59

0.09 (0.07%)

06:09
11/19/18
11/19
06:09
11/19/18
06:09
Periodicals
Salesforce CEO defends contract with Customs and Border Patrol, Recode reports »

Salesforce CEO Marc…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 19

    Nov

  • 20

    Nov

  • 27

    Nov

  • 27

    Nov

  • 28

    Nov

  • 29

    Nov

  • 06

    Dec

  • 11

    Dec

  • 03

    Mar

OSK

Oshkosh

$66.91

-0.46 (-0.68%)

06:09
11/19/18
11/19
06:09
11/19/18
06:09
Conference/Events
Oshkosh management to meet with Buckingham »

Meetings to be held in…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 19

    Nov

  • 20

    Nov

  • 04

    Dec

  • 05

    Dec

VICI

VICI Properties

$21.29

0.16 (0.76%)

06:09
11/19/18
11/19
06:09
11/19/18
06:09
Initiation
VICI Properties initiated  »

VICI Properties initiated…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 28

    Nov

CARG

CarGurus

$38.76

0.31 (0.81%)

06:08
11/19/18
11/19
06:08
11/19/18
06:08
Initiation
CarGurus initiated  »

CarGurus initiated with a…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 04

    Dec

KOP

Koppers Holdings

$20.18

-1.315 (-6.12%)

06:08
11/19/18
11/19
06:08
11/19/18
06:08
Conference/Events
Koppers Holdings management to meet with Seaport Global »

Meetings to be held in…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 19

    Nov

  • 20

    Nov

  • 26

    Nov

  • 27

    Nov

CMRE

Costamare

$5.35

0.01 (0.19%)

06:07
11/19/18
11/19
06:07
11/19/18
06:07
Hot Stocks
Costamare acquires 60% equity interest in five 14,000 TEU containerships »

Costamare announced the…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

Get Full Fly Access

Breaking market intelligence sent straight to you
Our team of experts analyze every news story and filter out the noise to deliver real-time market moving news.
Up-to-date information on important industry events
Get real-time updates on events that are moving the market—from conferences and calls to syndicate announcements.
News focused on the companies in your portfolio
Create up to 12 portfolios with 150 stocks each, and see how active they are in market news.